Financial reports
No filings
Current reports
No filings
Registration and prospectus
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
29 Dec 23
D/A
Indefinite amount in investment fund, sold $1.51 bn, 27 investors
30 Dec 22
D/A
Indefinite amount in investment fund, sold $1.11B, 26 investors
4 Jan 22
D/A
Indefinite amount in investment fund, sold $675.08M, 24 investors
7 Jan 21
D/A
Indefinite amount in investment fund, sold $413.83M, 19 investors
10 Jan 20
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
11 Jan 19
D/A
Indefinite amount in investment fund, sold $224.03M, 18 investors
8 Dec 17
D/A
Indefinite amount in investment fund, sold $212.03M, 17 investors
21 Sep 16
D/A
Indefinite amount in investment fund, sold $64.76M, 13 investors
12 Nov 14
D/A
Indefinite amount in investment fund, sold $41.66M, 14 investors
8 Nov 13
Proxies
DFAN14A
Additional proxy materials by non-management
23 Mar 09
DFAN14A
Additional proxy materials by non-management
20 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
13 Mar 09
DFAN14A
Additional proxy materials by non-management
12 Mar 09
DEFC14A
Proxy in contested solicitation
10 Mar 09
DFAN14A
Additional proxy materials by non-management
10 Mar 09
DFAN14A
Additional proxy materials by non-management
10 Feb 09
DFAN14A
Additional proxy materials by non-management
6 Feb 09
PRRN14A
Revised preliminary proxy statement filed by non-management
5 Feb 09
Ownership
4
MARK N LAMPERT
18 Jun 24
4
MARK N LAMPERT
10 Jun 24
SC 13G
Celcuity Inc.
10 Jun 24
SC 13G
Foghorn Therapeutics Inc.
30 May 24
SC 13G
PIERIS PHARMACEUTICALS, INC.
17 May 24
SC 13G
PIERIS PHARMACEUTICALS, INC.
17 May 24
4
MARK N LAMPERT
13 May 24
SC 13D/A
MoonLake Immunotherapeutics
5 Mar 24
SC 13G/A
enGene Holdings Inc.
22 Feb 24
SC 13G/A
Aclaris Therapeutics, Inc.
14 Feb 24